Inhalable vaccine developed by China may boost antibodies 300-fold
Beijing: An inhalable Covid-19 vaccine developed by China's CanSino Biologics has shown an increase of 250- to 300-fold in neutralising antibody levels as a booster shot, the media reported. According to latest lab studies by the Chinese drug maker, the aerosolised inhaled adenovirus Type-5 vector-based...